BIB
$84.96
AUM$86M
TER0.95%
Holdings256
BIB
$84.96
ProShares Ultra Nasdaq Biotechnology
AUM$86M
TER0.95%
Holdings256
✓All holdings
✓Overlap Analysis
✓ETF Screener
✓Compare ETFs
From$15/mo
View Plans →Fund Essentials - as of Oct 31, 2025
Net Assets
$86M
Expense Ratio
0.95%
Dividend Yield (Current)
1.05%
Holdings
256
Inception Date
Apr 6, 2010
Fund Family
ProShares
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Quarterly
Performance
YTD+0.04%
1 Year+0.53%
3 Year+0.40%
5 Year-0.15%
10 Year+1.12%
Asset Allocation
Stocks: 30.75%
Bonds: 3.48%
Other: 65.77%
Price Chart (6M)
View Full Chart →Top Holdings
View All →| Ticker | Name | Weight |
|---|---|---|
| - | Nasdaq Biotechnology Index Swap Citibank Na | 39.15% |
| - | NASDAQ Bio Index SWAP BNP Paribas | 29.52% |
| - | Nasdaq Biotechnology Index Swap Bank Of America Na | 21.47% |
| - | Nasdaq Biotechnology Index Swap Societe Generale | 19.22% |
| - | Nasdaq Biotechnology Index Swap Goldman Sachs International | 17.79% |
Top 10 Concentration: 157.60%Report Date: Oct 31, 2025
Dividend Summary
View Details →Dividend Yield (Current)
1.05%
Frequency
Quarterly
Latest Distribution
$0.18
Sep 24, 2025
12M Distributions
3 payments
Total: $0.48
Peer Comparison
Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
+4.38%
YTD
+53.44%
1 Year
+53.44%
3 Year
+40.11%
Top 10 Holdings (157.6% of portfolio)
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | - | Nasdaq Biotechnology Index Swap Citibank Na | Other | 39.15% |
| 2 | - | NASDAQ Bio Index SWAP BNP Paribas | Other | 29.52% |
| 3 | - | Nasdaq Biotechnology Index Swap Bank Of America Na | Other | 21.47% |
| 4 | - | Nasdaq Biotechnology Index Swap Societe Generale | Other | 19.22% |
| 5 | - | Nasdaq Biotechnology Index Swap Goldman Sachs International | Other | 17.79% |
| 6 | - | Nasdaq Biotechnology Index Swap Ubs Ag | Other | 8.94% |
| 7 | B 0 11/20/25 | Treasury Bill Nov 20, 2025 | Financials | 7.20% |
| 8 | VRTX | Vertex Pharmaceuticals Inc | Health Care | 4.89% |
| 9 | GILD | Gilead Sciences Inc | Health Care | 4.76% |
| 10 | AMGN | Amgen Inc. | Health Care | 4.66% |